Twentyeight-Seven Therapeutics is a biotechnology company focused on the modulation of non-coding RNA function to treat cancer and other human diseases. The Company is targeting RNA modulating proteins to use small molecules to control the expression levels of oncogenes and other proteins of significance.
Type | Private | |
Founded | 2016 | |
HQ | Watertown, MA, US | Map |
Website | twentyeight-seven.com |
Employees (est.) (Feb 2021) | 19 | |
Cybersecurity rating | A | More |
Founding Date | 2016 |
Twentyeight-Seven Therapeutics total Funding | $80 m |
Twentyeight-Seven Therapeutics latest funding size | $15 m |
Time since last funding | 2 years ago |
Twentyeight-Seven Therapeutics investors | MPM Capital, Sofinnova Partners, Novartis Venture Fund, Astellas Venture Management, Johnson & Johnson Innovation, Vertex Ventures, Vertex Ventures HC, Longwood Fund |
When was Twentyeight-Seven Therapeutics founded?
Twentyeight-Seven Therapeutics was founded in 2016.
Who are Twentyeight-Seven Therapeutics key executives?
Twentyeight-Seven Therapeutics's key executives are Luke Evnin, Shomir Ghosh and Briggs Morrison.
How many employees does Twentyeight-Seven Therapeutics have?
Twentyeight-Seven Therapeutics has 19 employees.
Who are Twentyeight-Seven Therapeutics competitors?
Competitors of Twentyeight-Seven Therapeutics include Day One Biopharmaceuticals, Pinteon Therapeutics and Pathios Therapeutics.
Where is Twentyeight-Seven Therapeutics headquarters?
Twentyeight-Seven Therapeutics headquarters is located at 490 Arsenal Way #100B, Watertown.
Where are Twentyeight-Seven Therapeutics offices?
Twentyeight-Seven Therapeutics has an office in Watertown.
How many offices does Twentyeight-Seven Therapeutics have?
Twentyeight-Seven Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies